WST
West Pharmaceutical Services, Inc.
Stock
$364.98−0.03 (−0.01%)Close Oct 2, 2026
- Operating cash flow, 2025
- $755M
- YoY, 2025
- +15.5%
- 5-year CAGR
- +9.8%
- 10-year CAGR
- +13.5%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $755M | +15.5% |
| 2024 | $653M | −15.9% |
| 2023 | $777M | +7.3% |
| 2022 | $724M | +24.0% |
| 2021 | $584M | +23.6% |
| 2020 | $473M | +28.7% |
| 2019 | $367M | +27.2% |
| 2018 | $289M | +9.6% |
| 2017 | $263M | +20.0% |
| 2016 | $219M | +3.3% |
| 2015 | $212M | +16.1% |
| 2014 | $183M | −17.1% |
| 2013 | $221M | +17.7% |
| 2012 | $187M | +43.4% |
| 2011 | $131M | −5.5% |
| 2010 | $138M | +0.4% |
| 2009 | $138M | +2.0% |
| 2008 | $135M | — |